These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 32037398)

  • 1. Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex.
    Jung YS; Park JI
    Exp Mol Med; 2020 Feb; 52(2):183-191. PubMed ID: 32037398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities.
    Liu J; Xiao Q; Xiao J; Niu C; Li Y; Zhang X; Zhou Z; Shu G; Yin G
    Signal Transduct Target Ther; 2022 Jan; 7(1):3. PubMed ID: 34980884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration.
    Bastakoty D; Young PP
    FASEB J; 2016 Oct; 30(10):3271-3284. PubMed ID: 27335371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling in development and tissue homeostasis.
    Steinhart Z; Angers S
    Development; 2018 Jun; 145(11):. PubMed ID: 29884654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signaling in cancers and targeted therapies.
    Yu F; Yu C; Li F; Zuo Y; Wang Y; Yao L; Wu C; Wang C; Ye L
    Signal Transduct Target Ther; 2021 Aug; 6(1):307. PubMed ID: 34456337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.
    White BD; Chien AJ; Dawson DW
    Gastroenterology; 2012 Feb; 142(2):219-32. PubMed ID: 22155636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application.
    Li Q; Sun M; Wang M; Feng M; Yang F; Li L; Zhao J; Chang C; Dong H; Xie T; Chen J
    Cancer Sci; 2021 May; 112(5):1695-1706. PubMed ID: 33605517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
    Dzobo K; Thomford NE; Senthebane DA
    OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Wnt/β-catenin signaling pathway in human cancers.
    Yao H; Ashihara E; Maekawa T
    Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The canonical way to make a heart: β-catenin and plakoglobin in heart development and remodeling.
    Piven OO; Winata CL
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1735-1745. PubMed ID: 28920469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of Wnt/β-catenin pathway in tissue development and regenerative medicine.
    Majidinia M; Aghazadeh J; Jahanban-Esfahlani R; Yousefi B
    J Cell Physiol; 2018 Aug; 233(8):5598-5612. PubMed ID: 29150936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Zhang Y; Wang X
    J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic insights into WNT/β-catenin signaling.
    Rosenbluh J; Wang X; Hahn WC
    Trends Pharmacol Sci; 2014 Feb; 35(2):103-9. PubMed ID: 24365576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/beta-catenin signaling and small molecule inhibitors.
    Voronkov A; Krauss S
    Curr Pharm Des; 2013; 19(4):634-64. PubMed ID: 23016862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTORC1 signaling suppresses Wnt/β-catenin signaling through DVL-dependent regulation of Wnt receptor FZD level.
    Zeng H; Lu B; Zamponi R; Yang Z; Wetzel K; Loureiro J; Mohammadi S; Beibel M; Bergling S; Reece-Hoyes J; Russ C; Roma G; Tchorz JS; Capodieci P; Cong F
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10362-E10369. PubMed ID: 30297426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.
    Sun X; He Y; Huang C; Ma TT; Li J
    Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lens regeneration from the cornea requires suppression of Wnt/β-catenin signaling.
    Hamilton PW; Sun Y; Henry JJ
    Exp Eye Res; 2016 Apr; 145():206-215. PubMed ID: 26778749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
    Cheng X; Xu X; Chen D; Zhao F; Wang W
    Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in targeting the WNT/β-catenin signaling pathway in cancer.
    Chatterjee A; Paul S; Bisht B; Bhattacharya S; Sivasubramaniam S; Paul MK
    Drug Discov Today; 2022 Jan; 27(1):82-101. PubMed ID: 34252612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.